Showing results (411-420 of 993) with videos related to

Sort By:
Pageof 100
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosisC Qin, C Wilson, C Blancher, et al.
Anticancer Research|December 17, 1998
Bcl-2 and p53 expression in stage I endometrial carcinomaA Giatromanolaki, E Sivridis, M I Koukourakis, et al.
British Journal of Cancer|January 1, 1994
bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancerR D Leek, L Kaklamanis, F Pezzella, et al.
Cancer Research|August 1, 1993
Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancerS LeJeune, R Leek, E Horak, et al.
Cancer Research|February 15, 1997
The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivoL Griffiths, G U Dachs, R Bicknell, et al.
British Journal of Cancer|July 1, 1993
The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survivalD Veale, N Kerr, G J Gibson, et al.
European Journal of Nutrition|June 21, 2021
Types of carbohydrate intake and breast cancer survivalMaryam S Farvid, Junaidah B Barnett, Nicholas D Spence, et al.
The Canadian Journal of Cardiology|July 1, 1994
Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapyY Lacourcière, F Leenen, R Rangno, et al.
Canadian Medical Association Journal|December 15, 1984
Increased prevalence of mitral valve prolapse in patients with migraineJ D Spence, D G Wong, L J Melendez, et al.
British Journal of Clinical Pharmacology|August 1, 1995
Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulationD G Bailey, J M Arnold, J R Bend, et al.
Pageof 100